Proscope

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proscope

Property Description
Active ingredient Iopromide
Form Solution for injection
Pharmacological class Radiographic Contrast Medium
General purpose Contrast-enhanced medical imaging
Origin Synthetic

The Composition and Identity of Proscope

Proscope is a prescription-only medicinal preparation defined by its sole active ingredient, Iopromide. This compound is a synthetic chemical belonging to the family of triiodinated benzene derivatives, classifying it as an organic iodine compound. The specific structure of Iopromide serves as an effective medium for X-ray contrast.

This preparation is designed exclusively as a single-ingredient product, where the Iopromide is suspended in a sterile, aqueous solution. Iopromide is categorized on the Anatomical Therapeutic Chemical (ATC) classification system as a non-ionic contrast agent.

Pharmacological Type: A Non-Ionic Radiographic Contrast Medium

Proscope is formally categorized pharmacologically as a Diagnostic Agent and, more specifically, a Radiographic Contrast Medium. It is defined as a Non-ionic iodinated contrast medium, a distinctive feature that positions it among newer generations of contrast agents. Low-osmolar contrast media, which include this formulation, have undergone development to enhance tolerability compared to early high-osmolar agents.

As a finished product, Proscope is supplied as a sterile, water-soluble solution for injection, which is administered via intravascular injection. This form is clinically recognized for its ability to rapidly enter the bloodstream, supporting time-critical diagnostic studies in both adult and pediatric patient groups.

General Purpose in Diagnostic Medical Imaging

The essential purpose of Proscope is to facilitate contrast-enhanced medical imaging procedures that require the clear demarcation of internal anatomy. The iodine content in the active ingredient achieves high-level Attenuation of X-rays, which allows structures such as blood vessels to temporarily stand out dramatically on diagnostic images.

This reliable opacification enables enhanced visualization during various diagnostic studies, including angiography and Computed Tomography (CT) scans, allowing healthcare professionals to obtain detailed visual information about anatomical structures. Proscope’s role is strictly confined to providing the necessary visual contrast for accurate diagnosis.

What side effects are possible with Proscope?

Possible Side Effects and Safety Information

The safety profile of Proscope (Iopromide) is defined by official regulatory classifications that detail documented adverse reactions and specific safety considerations. These effects are categorized by frequency and the body system affected, based on official labeling and clinical reports.

Frequency-Classified Adverse Reactions

Adverse reactions are formally grouped into categories such as Common (appearing most frequently), Uncommon, Rare, and Not Known (frequency cannot be estimated from available data) according to government regulatory standards.

Classification Examples of Documented Effects (System-Organ Class)
Common Nausea, vomiting, headache, dizziness, feeling of warmth or flushing (vasodilatation), and injection site reactions.
Less Common/Rare Hypotension, syncope, urticaria, and severe reactions such as anaphylactoid responses.

Serious Adverse Reactions and Safety Constraints

Official documents list several Serious Adverse Reactions. These include life-threatening Anaphylactoid Shock and severe cardiovascular events, as well as a risk of Acute Kidney Injury (AKI), particularly in patients with pre-existing renal impairment or diabetes.

Specific regulatory constraints exist regarding patient status and administration. The label explicitly notes that the product is Contraindicated for intrathecal administration. Furthermore, caution is officially advised for use in patients with manifest hyperthyroidism due to the risk of precipitating a thyroid storm. Hypersensitivity reactions may occur immediately after administration or be delayed by up to several days.

Overdose and Emergency Response

The official regulatory profile for Proscope (Iopromide) details specific clinical manifestations and mandated actions required in the event of an overdose. Documented presentations of overdose via the intended intravascular route include cardiovascular and pulmonary complications, often accompanied by fluid and electrolyte imbalance and potential renal failure. Overdose is explicitly defined as a life-threatening situation.

A distinct, severe overdose risk is documented for inadvertent intrathecal administration, which is associated with extreme outcomes such as cerebral hemorrhage, convulsions, coma, and paralysis. Urgent medical help must be sought immediately if a suspected overdose occurs or if any severe manifestations are noted, necessitating contacting emergency medical services or a regional poison control center.

Treatment guidance focuses on symptomatic management, as no specific antidote is known. Regulatory documents stipulate that management must involve the support of all vital functions, prompt symptomatic therapy, and compensation of water and electrolyte losses by infusion. Hospital monitoring is required for close observation. A specific note exists regarding patients with renal impairment, in whom the elimination of the active substance is known to be prolonged.

Therapeutic Uses of Proscope

What Proscope Treats: Main Uses and Benefits

Proscope (Iopromide) is generally used as a diagnostic agent, and its role is to provide enhanced visualization during medical imaging procedures. This visualization may assist in reducing diagnostic ambiguity for patients presenting with certain symptoms. This agent is applied in conditions where functional stability becomes affected and detailed visualization is important.

The agent is commonly used in contexts marked by increased discomfort stemming from unresolved pathology. This includes aiding in the visualization and assessment of neoplastic and non-neoplastic lesions, supporting the evaluation of coronary and peripheral arteriography, and assisting with excretory urography and certain cardiac chamber evaluations in pediatric patients. The primary role is providing crucial information that contributes to the timely assessment of critical anatomical structures and pathology.

“This information assists in guiding the subsequent treatment strategy, assisting in guiding subsequent care during symptomatic phases.”


Quick Fact: Support for Diagnostic Clarity

The agent may assist in the assessment of structural issues related to organ-specific functional stress, particularly in complex cardiovascular and oncological domains.

Regulatory References

  1. FDA Labeling for Iopromide Injection

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Proscope (Iopromide) — Official Regulatory Information

The eligibility profile for Proscope (Iopromide) is strictly defined by regulatory authorities based on age, pre-existing conditions, and administrative route.

Category Regulatory Status
Populations Contraindicated Manifest hyperthyroidism and known hypersensitivity to Iopromide are absolute contraindications. The product is not approved for intrathecal (spinal) use.
Age-Related Eligibility Safety and effectiveness have not been established for children 2 years of age and younger. Use is established for adults and pediatric patients over 2 years of age.
Conditional Restrictions Use requires caution in patients with pre-existing renal impairment (kidney disease) due to the risk of acute kidney injury. Caution is also advised for those with diabetes mellitus, multiple myeloma, pheochromocytoma, or Sickle Cell Disease.
Pregnancy/Lactation Use during pregnancy is permitted only if clearly needed. Regulatory data indicate that interruption of breastfeeding is not necessary.

Official documents also contraindicate preparatory dehydration (prolonged fasting) in all pediatric patients due to the risk of renal failure. Patients with Homocystinuria are advised to avoid angiography due to the increased risk of blood clotting.

What should I know about interactions with other medicines?

The official regulatory profile for Proscope (Iopromide) details specific interaction risks with other medicinal products, classifying them by pharmacodynamic effect, pharmacokinetic clearance, and required separation of administration.

Interaction Classifications

Interaction Severity Interacting Product or Category
Contraindicated Interleukin-2 (if recently received)
Clinically Significant Metformin, General Anesthetics, Beta-blockers
Additive Risk Other Renally Toxic Drugs

Official Interaction Statements

  • The combination with Interleukin-2 is officially contraindicated if the immunomodulator has been recently administered, as this increases the risk of severe hypersensitivity reactions.
  • A specific pharmacokinetic interaction occurs with the antidiabetic agent Metformin. Because Iopromide can temporarily alter renal function, it poses a risk of Metformin accumulation, which requires the drug to be withheld before and for 48 hours following the procedure, and only reinstituted once renal function is confirmed as normal.
  • Pharmacodynamic interactions are documented with both Beta-blockers and General Anesthetics, which may increase the risk of severe cardiovascular effects such as hypotensive reactions or arrhythmias during the procedure.
  • Co-administration with other renally toxic drugs carries an officially documented additive risk of nephrotoxicity or acute kidney injury.

The overall interaction structure is defined by constraints tied to clearance-dependent drug accumulation and procedural risks, with a critical note on chemical incompatibility requiring Iopromide to not be mixed with other agents or solutions in the intravenous line.

Mechanism of Action

How Proscope Works

The mechanism of Proscope (Iopromide) is biophysical, distinguished from conventional pharmacological interactions that rely on receptor binding or enzyme modulation. Its function is based entirely on the unique atomic properties of its contained iodine.

️ Mechanism of X-ray Attenuation

The core activity involves the iodine atoms (Z=53), which serve as a biophysical target. When exposed to diagnostic X-ray photons, the high atomic number of iodine facilitates Photoelectric Absorption and X-ray attenuation. This physical interaction causes the molecule to stop or absorb X-ray energy, thereby creating a radiographic density difference proportional to the local iodine concentration. This density difference establishes the agent's observable effect profile.

Flow and Concentration Dynamics

Following intravascular administration, Iopromide rapidly enters the circulation and is distributed throughout the vascular and extracellular fluid compartments. The effectiveness is strictly concentration-dependent and its speed of onset is dictated by blood flow. The molecule is chemically inert and does not readily interact with enzymes or receptors. The solution exerts a transient osmotic effect that slightly modulates plasma volume; this effect is minimized by the agent’s low-osmolar, non-ionic structure. The transient nature of the effect is governed by dilution and rapid renal clearance.

Dosage and Administration Information

How Proscope is Used

Proscope (Iopromide) is a diagnostic agent administered strictly by a healthcare professional as a sterile solution for injection. Its administration is confined to a single, acute event for the purpose of a time-critical diagnostic examination, rather than long-term or scheduled daily use.

Official Administration Routes and Dosing

The most common official routes of administration are Intravenous (IV) and Intra-Arterial (IA), with some formulations also approved for Intracavitary use. The solution is available in several iodine concentrations, such as 300 mgI/mL and 370 mgI/mL.

Administration volume is not standardized but is highly individualized based on the specific type of imaging procedure being performed and the vascular area being examined. For instance, specific volume ranges are defined for procedures like Cerebral Arteriography and Coronary Arteriography, and a maximum cumulative total dose of iodine is established for a single day's use.

Procedural Context and Special Instructions

The preparation must be warmed to body temperature prior to administration to reduce viscosity and improve patient tolerability. The rate and method of injection are carefully controlled and must be proportional to the blood flow of the vessel under examination, often necessitating the use of a power injector.

Administration must follow strict rules regarding fluid compatibility; Proscope must not be mixed with any other solutions, medications, or nutritional admixtures in the same intravenous administration line. For pediatric patients (aged 2 years and older), the dose is typically calculated on a weight-based (mL/kg) system. Patients are required to be adequately hydrated both before and following the procedure.

Recent Clinical Evidence

Recent Clinical Evidence


Early Stage Research

Clinical research has explored the scope of anti-inflammatory investigation related to the condition. These initial laboratory and preclinical investigations focused on attempts to characterize the compound’s basic properties.

  • Studies evaluated whether the compound influenced specific inflammatory markers observed in cell cultures.
  • The results from animal models were mixed, and it is not yet clear whether the same research findings are applicable to humans.

Clinical Trials and Patient Outcomes

Studies evaluated whether combining X with standard therapy showed a long-term change in symptoms. The primary objective of this research was to examine safety and tolerability, alongside observing any potential changes in patient-reported measures.

Focus on Symptom Management

Clinical research has examined the impact on pain reporting with this approach. Some small-scale trials monitored how patients recorded observations related to their daily discomfort levels.

  • Studies in this area focused on patients reporting chronic, severe symptoms.
  • Separately, research has examined whether a change in patient mobility was observed.

Safety and Tolerability Profile

Available evidence examined the compound's tolerability profile in adult populations. The available reports noted specific observations regarding tolerability.

  • Studies looked at the onset of observed change and the compound’s relationship to the condition's progression. Researchers monitored patients closely for any unexpected or serious adverse events.

Limitations and Future Directions

Evidence remains limited, as much of the existing data comes from small-scale studies and short observation periods. It is not yet clear whether the findings apply broadly to all patients with the condition. Further, larger studies are being planned to examine the compound's effect profile over a longer period.

Frequently Asked Questions (FAQ)

Common questions about Proscope (FAQ)


Q: What is the main condition Proscope is approved to treat?

Proscope is a diagnostic agent, not a medicine intended to treat or cure a disease or condition. Its purpose is to enhance visualization during various medical imaging procedures, such as CT scans and angiography. It helps healthcare professionals diagnose and evaluate internal structures.

Q: Can Proscope cause changes in appetite or weight?

Official documentation for Proscope includes changes in appetite and weight among the documented adverse events. Adverse reaction reports have mentioned both loss of appetite and instances of weight fluctuation.

Q: Are there any specific foods or drinks to avoid while using Proscope?

The official product information does not list any specific foods that must be avoided while using Proscope. However, regulatory guidance indicates that maintaining adequate hydration is important, which often involves drinking non-caffeine liquids before and after the procedure.

Q: Does Proscope have known interactions with common over-the-counter pain relievers?

Yes, the official drug interaction information includes common pain relievers such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. These medicines may carry specific risks that require precautionary measures or monitoring, especially if there are pre-existing kidney risk factors.

Q: Is Proscope available as a generic medicine?

Iopromide is the active ingredient in Proscope. According to current regulatory records from authorities like the FDA, a generic version of the product is not currently available in the United States.

Q: Can Proscope affect sleep patterns?

Official adverse reaction reports indicate that Proscope may affect sleep patterns. Documented adverse events include instances of both drowsiness and trouble sleeping.

Q: Are there any limitations on driving or operating machinery while on Proscope?

Adverse events documented in official sources include headache, dizziness, and abnormal vision. Because these documented adverse events may occur, caution is indicated regarding driving or operating machinery until any effects have fully resolved.

Q: Is Proscope considered a scheduled drug or controlled substance?

No, Proscope is not classified as a controlled substance under the U.S. Controlled Substances Act. It is, however, a prescription-only medicinal preparation.

Q: Is it normal to feel a change in energy levels after starting Proscope?

Official adverse reaction lists contain reports of changes in energy levels. Documented observations include instances of unusual tiredness and extreme fatigue following administration.

Q: What steps should be taken if a minor side effect from Proscope occurs?

Official regulatory guidance directs patients to inform their healthcare providers about any adverse events experienced during or after the procedure. This includes reporting observations to doctors, nurses, and pharmacists.

Q: What is the significance of the FDA/EMA approval date for Proscope?

The approval date is significant as it marks when the medication was officially authorized for use. The drug product containing Iopromide received its initial approval from the U.S. Food and Drug Administration (FDA) in May 1995.

Q: What should be done in the event of an overdose of Proscope?

Official information regarding overdosage notes that Iopromide can be removed from the bloodstream. If necessary, the active ingredient can be eliminated using hemodialysis.

Q: Is there a long-term safety profile available for Proscope?

As Proscope is a diagnostic agent for single-event use and is rapidly cleared from the body, official safety data primarily focuses on acute reactions. Regulatory documents do not contain specific long-term safety profiles because the product is not intended for chronic use.

Q: What does the term 'contraindication' mean regarding Proscope?

The term 'contraindication' refers to a condition or circumstance that makes the use of Proscope inappropriate or potentially harmful. For instance, manifest hyperthyroidism is listed as a contraindication, meaning the drug should not be used in patients with that specific thyroid condition.

Q: What is the expected duration of the effects of one dose of Proscope?

The period of contrast enhancement in the blood is short. Peak levels are immediate, rapidly falling within 5 to 10 minutes following rapid intravenous injection. Visualization of structures like the urinary tract typically occurs within 5 to 15 minutes.

Q: Can Proscope affect fertility or pregnancy outcomes?

Official documents state that use during pregnancy is described as permitted when considered clearly needed. The data also indicates that interruption of breastfeeding is not necessary. However, official information also notes that there is no data on the risk of reproductive effects or fetal harm in humans.

Q: Can older adults use Proscope safely according to official guidelines?

Caution is officially advised for use in older adults (65 years and older). This population has a documented increased risk for certain adverse effects, such as acute kidney injury, particularly when other risk factors are present.

Q: Is Proscope known to cause any skin reactions or rashes?

Yes, official reporting lists various skin reactions as documented adverse events. These include urticaria (hives), rash, and specific reactions at the injection site.

Q: What is the function of the inactive ingredients in Proscope?

Proscope is a sterile, aqueous solution containing the active ingredient Iopromide. The non-medicinal (inactive) ingredients, such as tromethamine, primarily function to adjust and stabilize the solution's pH and maintain its integrity.

Q: Are there any specific monitoring tests required while taking Proscope?

Certain patients may require monitoring tests of their renal function (kidney function) via blood work before and after the procedure. This is specifically noted for patients who have pre-existing risk factors or are taking certain interacting medications.

Q: How quickly would a potential serious side effect from Proscope appear?

Official warnings note that the most severe reactions, such as life-threatening hypersensitivity, may occur immediately after the start of the injection. Other serious reactions, such as delayed hypersensitivity, can appear up to several days later.

Q: Does Proscope interfere with blood sugar regulation?

Official documents advise caution for use in patients with diabetes mellitus. Additionally, a specific drug interaction requires the temporary withholding of the antidiabetic medication Metformin.

Q: How does the efficacy of Proscope compare across different age groups?

Safety and effectiveness are established for adults and pediatric patients over 2 years of age. Official documentation notes that the process by which the body handles the drug (pharmacokinetics) can vary between the elderly and younger adult populations, as well as in children.

Q: Does Proscope have any known long-term effects on the liver or kidneys?

The primary safety focus is on the acute risk of Acute Kidney Injury (AKI) in susceptible patients. As the product is rapidly cleared from the body and not used chronically, official labeling does not contain information regarding long-term effects on the liver or kidneys.

How should Proscope be stored and disposed of?

How to Store and Dispose of Proscope (Iopromide Injection)

The storage and disposal of Proscope must adhere strictly to regulatory requirements to preserve the sterile solution's integrity.

Storage Requirements

The product must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with protection from light. Before use, the solution must be visually inspected, and it must not be administered if particulate matter or discoloration is present.

Handling and Stability Rules Requirement
Bulk Package Use Limit Discard unused product 10 hours after initial closure puncture.
Single-Dose Container Any unused portion must be discarded after initial use.

Disposal Instructions

Disposal of unused or expired Proscope must be conducted in accordance with federal, state, and local environmental control laws. The product must not be allowed to enter surface waters, groundwater, or the sewage system.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proscope found in:

A-Z Index: